Mental Health

WELL Health Provides a Capital Allocation Update Reflecting the Addition of $100M in Annualized Revenue from Acquisitions Completed Since December 2024

WELL completed seven acquisitions since December 2024 across its Canadian Clinics, WELLSTAR and WELL USA business units, collectively representing total…

11 months ago

Trellus Health to Bring Holistic Support to Patients, Working With a Pharmaceutical Company

Trellus Health to Bring Holistic Support to Patients, Working With a Pharmaceutical Company LONDON and NEW YORK, Jan. 14, 2025…

11 months ago

Alter Behavioral Health Opens New Residential Mental Health Facility in Irvine, California

Alter Behavioral Health, a Pioneer in Transformative Mental Health Care, Celebrates the Grand Opening of Its Brand-New Residential Mental Health…

11 months ago

400+ Kentucky Educators, Support Staff Receive Access to Groundbreaking Digital Stress Management Platform

Ohio Valley Educational Cooperative (OVEC) partners with Bounceback to help educators identify and effectively manage stress NASHVILLE, Tenn., Jan. 13,…

11 months ago

Core Solutions Launches Ambient Documentation for Behavioral Health

Innovative Cx360 GO artificial intelligence-powered solution impressively combines simplicity and affordability KING OF PRUSSIA, Pa., Jan. 13, 2025 /PRNewswire/ --…

11 months ago

Clinical Trial of NeuroSigma’s Monarch eTNS System for ADHD at King’s College London Completes Enrollment

ATTENS (ADHD trial of external trigeminal nerve stimulation) Project, led by Professor Katya Rubia at the Institute of Psychiatry, Psychology…

11 months ago

Optimi Health Reports First Patients Dosed in Landmark Natural Psilocybin Study in New Zealand

The Company's natural psilocybin extract powers a culturally transformative study to address methamphetamine addiction through indigenous frameworks.Vancouver, British Columbia--(Newsfile Corp.…

11 months ago

Universal Brain Announces Publication of Groundbreaking Depression Research Using Multiple Event-Related Potentials

New findings support the company's neuroscience-driven approach to precision psychiatry, offering actionable insights for personalized depression treatment PALO ALTO, Calif.,…

12 months ago

HMNC Brain Health Completes Patient Randomization for Phase 2b OLIVE Trial for Major Depressive Disorder

Study Marks Milestone in Precision Psychiatry for Stress-Axis-Related DepressionMUNICH, Jan. 10, 2025 (GLOBE NEWSWIRE) -- HMNC Brain Health (“HMNC”), a…

12 months ago